GC Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 45

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $65M

  • Investors
  • 16

GC Therapeutics General Information

Description

Developer of a genome-wide cell programming platform designed to convert stem cells into multiple cell types. The company utilizes synthetic biology and proprietary differentiation technology to program cell fate and enable scalable cell production, enabling healthcare providers to access cell therapies with improved manufacturing efficiency.

Contact Information

Website
www.gc-tx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 610 Main Street
  • Cambridge, MA 02139
  • United States
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 610 Main Street
  • Cambridge, MA 02139
  • United States

GC Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GC Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) 19-Sep-2024 $65M Completed Generating Revenue
6. Accelerator/Incubator 10-Apr-2023 Completed Generating Revenue
5. Seed Round 09-Feb-2021 Completed Generating Revenue
4. Accelerator/Incubator 24-Sep-2019 Completed Generating Revenue
3. Grant 02-May-2019 Completed Startup
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 01-May-2019 Completed Startup
To view GC Therapeutics’s complete valuation and funding history, request access »

GC Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view GC Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

GC Therapeutics Patents

GC Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025147551-A1 Methods and compositions for stem cell differentiation Inactive 03-Jan-2024
EP-4828957-A1 Methods and compositions for stem cell differentiation Pending 20-Dec-2023
WO-2025137379-A1 Methods and compositions for stem cell differentiation Inactive 20-Dec-2023
EP-4547822-A2 Methods and compositions for stem cell differentiation Pending 30-Jun-2022
EP-4547822-A4 Methods and compositions for stem cell differentiation Pending 30-Jun-2022 C12N5/0634
To view GC Therapeutics’s complete patent history, request access »

GC Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GC Therapeutics Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alumni Ventures Venture Capital Minority
Calm Ventures Venture Capital Minority
Cercano Management PE/Buyout Minority
Cormorant Asset Management PE/Buyout Minority
Gaingels Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

GC Therapeutics FAQs

  • When was GC Therapeutics founded?

    GC Therapeutics was founded in 2019.

  • Where is GC Therapeutics headquartered?

    GC Therapeutics is headquartered in Cambridge, MA.

  • What is the size of GC Therapeutics?

    GC Therapeutics has 45 total employees.

  • What industry is GC Therapeutics in?

    GC Therapeutics’s primary industry is Biotechnology.

  • Is GC Therapeutics a private or public company?

    GC Therapeutics is a Private company.

  • What is the current valuation of GC Therapeutics?

    The current valuation of GC Therapeutics is .

  • What is GC Therapeutics’s current revenue?

    The current revenue for GC Therapeutics is .

  • How much funding has GC Therapeutics raised over time?

    GC Therapeutics has raised $74.7M.

  • Who are GC Therapeutics’s investors?

    Alumni Ventures, Calm Ventures, Cercano Management, Cormorant Asset Management, and Gaingels are 5 of 16 investors who have invested in GC Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process